Novo Nordisk has plans to become the first pharmaceuticals firm to be using 100% renewable energy sources by 2030. The company is already well on the way to making a complete switch to renewable energy sources for all its production facilities by the end of 2020, assisted by its new 672-acre solar panel installation in North Carolina which will provide power to its entire US operations by then. This strategy is in line with Novo Nordisk’s Circular for Zero environmental strategy, part of which aims to accomplish its mission of zero CO2 emissions from all operations and transport by 2030, and eventually having zero impact on the environment.
President and CEO of Novo Nordisk, Lars Fruergaard Jørgensen, said: "More than 29m people use our medicines and from early next year, they can do so knowing that they're produced using only renewable electricity. By committing to achieve zero emissions across our operations we are working towards a day when we will be able to say that Novo Nordisk is a company with zero environmental impact."
“By committing to achieve zero emissions ...we are working towards a day when we will be able to say that Novo Nordisk is a company with zero environmental impact."“
Ellen MacArthur Foundation are collaborating with Novo Nordisk on this strategy. Their CE100 Lead, Joe Murphy, said: "We are happy that Novo Nordisk has become the first pharmaceutical company to join CE100, which is the world's leading circular economy network. Novo Nordisk brings a track record of delivering on their commitments, having already shifted to 100% renewable power within its production. With its 10-year ambition to implement circularity across the company, Novo Nordisk now belongs to a select group of leading organisations who are breaking new ground on the transition to a circular economy."